Shares of medical technology company Integer Holdings (NYSE:ITGR) jumped 3.4% in the morning session after the company ...

It wasn't hard to be more positive on Integer's prospects. The company grew sales by 5% year over year to $472 million in its ...

Delivered 8% sales growth and 21% adjusted EPS growth in full year 2025 ~ ~ 2026 Outlook maintains midpoint of sales growth and high end of ...

Medical technology company Integer Holdings (NYSE:ITGR) reported in Q4 CY2025, with sales up 5% year on year to $472.1 ...

Fintel reports that on February 20, 2026, Benchmark upgraded their outlook for Integer Holdings (NYSE:ITGR) from Hold to Buy.

Q4 2025 earnings call recap: results, 2026 guidance, product headwinds, margins, and buybacks—get key takeaways now.

PLANO, Texas, Jan. 10, 2024 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (ITGR), a leading medical device outsource manufacturer, today announced fourth quarter 2023 preliminary unaudited sales ...

Detailed price information for Spyre Therapeutics Inc (SYRE-Q) from The Globe and Mail including charting and trades.

Integer Holdings (NYSE:ITGR) is gearing up to announce its quarterly earnings on Thursday, 2025-04-24. Here's a quick overview of what investors should know before the release. Analysts are estimating ...

Shares of Integer Holdings rose after the company reported sales growth in the fourth quarter and issued full-year guidance above Wall Street's expectations. Shares were up 3.8% to $89.51 late ...

Activist investor Irenic Capital Management has reportedly taken a more than 3% stake in Integer Holdings Corporation (NYSE: ITGR). It is pressing the medical-device outsourcing company to refresh its ...